Protocatechuic Acid Improves Alzheimer's Disease by Regulating the Cholinergic Synaptic Signaling Pathway
Chemistry & Biodiversity · 2025-05 · 22 (5)
DOI: 10.1002/cbdv.202402771 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 27.01.2025. Verfasst von Siwen Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Hydroxybenzoates, Neuroprotective Agents, Signal Transduction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Jilin Provincial Scientific and Technology Plan Projects.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is a prevalent neurodegenerative disorder characterized by memory decline and cognitive impairments. The clinical treatments for AD have numerous adverse effects; hence, the exploration of natural products for AD therapy is of significant importance. Protocatechuic acid (PA), a natural phenolic acid, has been shown to possess various pharmacological activities, including anti‐inflammatory, antioxidant, and antitumor effects. However, the mechanisms underlying its therapeutic potential for AD remain elusive. This study utilized a β‐amyloid (Aβ) injection into the hippocampus of mice as an AD model and L‐glu‐induced HT‐22 cell neurotoxicity and lipopolysaccharides (LPS)‐induced cellular neuroinflammation models to assess reactive oxygen species (ROS), JC‐1, and relevant biochemical markers. This study examined behavioral, pathological, and inflammatory factors and investigated the molecular mechanisms through transcriptomics, western blot, and molecular docking studies. This study's findings reveal that high‐dose PA (50 mg/kg) improves symptoms in AD mice through the cholinergic synaptic signaling pathway. This study indicates that PA is a potential candidate for AD treatment targeting the cholinergic synaptic signaling pathway, providing a lead compound for AD therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, China.
- International Joint Laboratory for Development of Animal and Plant Resources for Food and Medicine, Changchun, China.
- Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China.
- Synthèse des médicaments, CEA-CFOREM, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.
ORCID-Profile: Hongyan Zhu
Förderung
- Jilin Provincial Scientific and Technology Plan Projects
Zitieren
APA
Li, S., Li, S., Semde, R., Teng, H., Shi, M., Huang, L., Lou, X., Jia, B., Zhu, H., & Zhao, Y. (2025). Protocatechuic Acid Improves Alzheimer's Disease by Regulating the Cholinergic Synaptic Signaling Pathway. Chemistry & Biodiversity, 22(5). https://doi.org/10.1002/cbdv.202402771
Vancouver
Li S, Li S, Semde R, Teng H, Shi M, Huang L, et al. Protocatechuic Acid Improves Alzheimer's Disease by Regulating the Cholinergic Synaptic Signaling Pathway. Chemistry & Biodiversity. 2025;22(5). doi:10.1002/cbdv.202402771
BibTeX
@article{Li2025,
author = {Li, Siwen and Li, Songtao and Semde, Rasmané and Teng, Hongbo and Shi, Mengqi and Huang, Liang and Lou, Xinru and Jia, Beining and Zhu, Hongyan and Zhao, Yan},
title = {Protocatechuic Acid Improves Alzheimer's Disease by Regulating the Cholinergic Synaptic Signaling Pathway},
journal = {Chemistry & Biodiversity},
year = {2025},
volume = {22},
number = {5},
doi = {10.1002/cbdv.202402771}
}
EUVIMED